States Possibly the Best Bet for HHS Drug-Price Agenda
The Health and Human Services Department is pressuring Congress to take up its latest drug-pricing proposal for the commercial market, but Democrats have already rejected the idea.
You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.